A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Rosuvastatin 20 mg Film-coated Tablet and Reference Product (CRESTOR 20 mg) in Healthy Thai Volunteers under Fasting Conditions
Latest Information Update: 20 Nov 2020
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia
- Focus Pharmacokinetics
- 20 Nov 2020 New trial record